Loading Events

« All Events

  • This event has passed.

Advances in Cardiovascular Risk Reduction – NYU Langone Medical Center

May 20, 2016 @ 7:45 AM - 3:45 PM

This one-day course will cover state-of-the-art management of patients with cardiovascular risk factors, with a focus on prevention. This year’s program focuses on recent clinical trial results with implications in the management of cardiovascular disease risk factors, such as diabetes, hypertension, and ischemia. Additional topics include new developments in PCSK9 treatments for familial hypercholesterolemia, the use of aspirin in cardiac prevention and weight loss surgery insights. The course will also explore how environmental toxins can affect cardiovascular health.
Each year this course includes a research-oriented presentation that highlights bench-to-bedside relevance. This year the featured research-oriented presentation will focus on the latest in insulin resistance in type 2 diabetes.
Eight (8) half-hour presentations will be given. During lunch, attendees will participate in a case conference with challenging cases in cardiovascular disease risk reduction. Course participants are given the opportunity to submit questions to the featured speakers and panel members. The course will include a morning and afternoon panel discussion segment in which the questions from the audience are answered and debated among panel members.

Educational Objectives

At the conclusion of this activity, participants should be able to:

  • Discuss the EMPA-REG Outcome trial results and the potential impact on diabetes treatment approaches
  • Discuss recent scientific advances in the understanding of diabetes and related disorders
  • Describe the rationale behind the design of the SPRINT trial
  • Describe how PCSK9 modulates LDL levels and how PCSK9 expression is affected by statin treatment
  • Describe the rationale behind the ISCHEMIA trial and how this trial may affect standard of care in patients with stable ischemic heart disease
  • Summarize the role of aspirin in preventing cardiovascular events and their efficacy and safety in light of recent clinical trials
  • Describe surgical interventions for obesity and the effects on co-morbidities such as cardiovascular disease and diabetes
  • Describe the role of toxins, such as air pollution, as a risk for cardiovascular disease

Target Audience

Internists, family practitioners, cardiologists, general practice, endocrinologists and nurse practitioners with an interest in the prevention of heart disease.  Lecture, case conference and a Q&A panel discussion give learners multiple methods of instruction to interact with the information being presented.


May 20, 2016
7:45 AM - 3:45 PM
Event Categories:
, , , , ,


NYU Langone Medical Center
+1 212-263-5295


CPD Credits
Discount for members
Conference size


NYU Langone Medical Center
550 First Avenue
New York, NY 10016 United States
+ Google Map
+1 646-929-7870

Search Hotels

Check-in date
Check-out date